Community Home

Latest Discussion Posts

  • Join colleagues spanning the drug development lifecycle for an interactive, cross-sector conversation on New Approach Methodologies (NAMs), Sept. 10, at 1pm ET, by registering for Advancing NAMs Together: An Interactive Exchange of Insights & Expertise ...

  • Profile Picture

    Publications as promised

    There are lots of great articles on LLM. Based on Deedee's request at our meeting today, I am sharing two that might be of interest. I am also sharing the publication I referred to regarding amyloid peptide controversies. Either of these topics would ...

  • Virtual Webinar!!! The landscape is changing and it is imperative to develop and embrace new strategies. Join us Dr. Bo Tokarski Emmanuel Adediran, Ph.D for an insightful and practical session focused on Lifescience industry career ...

  • Dear Formulation & Delivery Community Members, AAPS recently introduced a new science-focused community structure and established the Formulation & Delivery Community , which comprises six scientific focus areas. I am pleased to contribute to this ...

    1 person recommends this.
  • For those following the NAM discussions in the US and EU, the EU has just advanced its position and plan in this Roadmap. The Objectives of the Roadmap section starts with a very clear set of statements on its intent: "This roadmap sets ...

    1 person recommends this.
  • USP has published four draft analytical method standards for biologic products and opened them for early stakeholder input - ahead of the formal compendial process . This pre-official window is a meaningful opportunity to help shape these methods before ...

  • The FDA is moving away from its traditional reliance on animal testing for preclinical safety evaluation. The agency is encouraging drug developers to incorporate New Approach Methodologies, such as AI-based modeling, organoids, and in vitro assays, along ...

  • Dear Translation & Clinical Science and Discovery & Preclinical Research Communities (Formerly Biomarkers and Precision Medicine), With multi-parameter biomarker platforms such as NULISA and Olink becoming increasingly mainstream, questions regarding ...

  • The submission deadline for Rapid Fire presentations at AAPS PharmSci 360 is coming up on June 12 at 5:00 PM ET . If you're planning to participate, now is a great time to review the Rapid Fire guidelines and prepare your materials for ...

  • Dear Community members, I am inviting you to submit your research papers, or scientific reviews to the Special Issue of European Journal of Pharmaceutical Sciences. The issue is devoted to use of AI, machine learning and modeling in pharmaceutical ...

Latest Shared Files